Skip to main content

Table 2 Distribution of msp2 alleles and complexity of infections over time

From: Maintenance of high temporal Plasmodium falciparum genetic diversity and complexity of infection in asymptomatic and symptomatic infections in Kilifi, Kenya from 2007 to 2018

Year

Asymptomatic infections

Febrile infections

n

Allelic type

COI (range)

He

n

Allelic type

COI (range)

He

FC27

n (%)

IC/3D7

n (%)

FC27 + IC/3D7 n (%)

FC27

n (%)

IC/3D7

n (%)

FC27 + IC/3D7 n (%)

2007

44

4 (4.0)

22 (17.2)

18 (9.9)

2.4 (1–7)

0.986

NA

NA

NA

NA

NA

NA

2008

65

20 (19.8)

33 (25.8)

12 (6.6)

1.7 (1–5)

0.969

1

1 (2.0)

NA

NA

1

NA

2009

45

12 (11.9)

11 (8.6)

22 (12.2)

2.7 (1–6)

0.959

19

13 (26.5)

3 (23.1)

3 (10.0)

2.1 (1–6)

0.968

2010

50

18 (17.8)

13 (10.2)

19 (10.5)

2.0 (1–7)

0.967

25

14 (28.6)

3 (23.1)

8 (26.7)

2.0 (1–6)

0.965

2011

48

13 (12.9)

16 (12.5)

19 (10.5)

2.5 (1–5)

0.975

18

12 (24.5)

2 (15.4)

4 (13.3)

1.6 (1–5)

0.953

2012

42

17 (16.8)

5 (3.9)

20 (11.0)

2.7 (1–8)

0.964

1

1 (2.0)

NA

NA

1

NA

2013

36

9 (8.9)

3 (2.3)

24 (13.3)

2.6 (1–5)

0.962

7

4 (4.2)

NA

3 (10.0)

2.4 (1–4)

0.963

2014

NA

NA

NA

NA

NA

NA

7

2 (4.1)

1 (7.7)

4 (13.3)

2.4 (1–4)

0.971

2015

43

3 (3.0)

13 (10.2)

27 (14.9)

2.2 (1–5)

0.959

5

1 (2.0)

1 (7.7)

3 (10.0)

2.2 (1–4)

NA

2016

21

2 (2.0)

6 (4.7)

13 (7.2)

3.0 (1–10)

0.975

4

1 (2.0)

2 (15.4)

1 (3.3)

1.5 (1–2)

NA

2017

10

1 (1.0)

5 (3.9)

4 (2.2)

2.7 (1–5)

0.966

3

NA

1 (7.7)

2 (6.7)

1.7 (1–2)

NA

2018

6

2 (2.0)

1 (0.8)

3 (1.7)

2.3 (1–5)

0.934

2

NA

NA

2 (6.7)

2.5 (2–3)

NA

Total (%)

410

101 (24.6)

128 (31.2)

181 (44.2)

2.3 (1–10)

0.975

92

49 (53.3)

13 (14.1)

30 (32.6)

2.0 (1–6)

0.964

  1. n corresponds to the number of successfully genotyped samples per year while % is the frequency per year. NA indicates non available data. The lack of amplifications in 2014 and 2019 was due to low parasitemia as a result of multiple DNA dilutions from previous studies. He refers to the expected heterozygosity. He was only calculated for 2009 to 2011 and 2013 to 2014 among the first-febrile where n was sufficient